Biochemistry Review for Medical Students

Biochemistry is the language of life at the molecular level, and for the physician, it is the essential key to diagnosing and understanding a vast array of diseases. Mastering its pathways transforms cellular diagrams into clinical insights, allowing you to connect a patient’s symptoms to a specific enzyme deficiency or metabolic blockade. This review distills high-yield concepts with direct clinical correlations, structuring your study for both medical coursework and rigorous board examinations like the USMLE.

Amino Acid Metabolism: More Than Building Blocks

Amino acids serve dual roles: as precursors for protein synthesis and as sources of carbon skeletons for energy production. Their metabolism is categorized into the fate of the amino group and the fate of the carbon skeleton. The central hub for amino group processing is the urea cycle, which occurs in the liver and converts toxic ammonia into excretable urea. Key enzymes here are carbamoyl phosphate synthetase I (CPS I) and ornithine transcarbamylase (OTC). Deficiencies in urea cycle enzymes lead to hyperammonemia, presenting in neonates with vomiting, lethargy, and cerebral edema.

The carbon skeletons of glucogenic amino acids (e.g., alanine, serine) can be converted to pyruvate or TCA cycle intermediates for gluconeogenesis, while ketogenic amino acids (e.g., leucine, lysine) yield acetyl-CoA or acetoacetate. Important clinical correlations stem from specific amino acid pathways. For instance, phenylalanine is hydroxylated to tyrosine by phenylalanine hydroxylase, requiring the cofactor tetrahydrobiopterin (BH4). A deficiency in the enzyme causes phenylketonuria (PKU), leading to intellectual disability if phenylalanine accumulates. Conversely, a deficiency in BH4 synthesis or recycling causes a similar presentation but also affects neurotransmitter synthesis.

Carbohydrate Metabolism: Cellular Energetics and Regulation

Carbohydrate metabolism centers on the extraction of energy from glucose. Glycolysis, occurring in the cytoplasm, converts one glucose to two pyruvate, yielding a net 2 ATP and 2 NADH. A crucial regulatory enzyme is phosphofructokinase-1 (PFK-1), inhibited by ATP and citrate and activated by AMP. Pyruvate’s fate depends on oxygen: aerobically, it enters mitochondria for conversion to acetyl-CoA by the pyruvate dehydrogenase complex (PDH), a set of enzymes dependent on thiamine (B1), lipoic acid, and other cofactors. PDH deficiency disrupts this link, causing lactic acidosis and neurological impairment.

Gluconeogenesis is the synthesis of glucose from non-carbohydrate precursors like lactate, glycerol, and glucogenic amino acids. It is not a simple reversal of glycolysis; it bypasses three irreversible steps using four key enzymes: pyruvate carboxylase, PEP carboxykinase, fructose-1,6-bisphosphatase, and glucose-6-phosphatase. Glycogen metabolism involves synthesis (glycogenesis) and breakdown (glycogenolysis). A classic high-yield correlation is von Gierke's disease (Type I glycogen storage disease), a deficiency in glucose-6-phosphatase. This prevents the liver from releasing free glucose into the blood, causing severe fasting hypoglycemia, hepatomegaly, lactic acidosis, and hyperlipidemia.

Lipid Metabolism: Fuel Storage and Signaling

Lipid metabolism involves the complex handling of fatty acids, cholesterol, and triglycerides. Fatty acid oxidation (beta-oxidation) occurs in the mitochondria, sequentially cleaving two-carbon units as acetyl-CoA. Carnitine is essential for transporting long-chain fatty acids into the mitochondrion via the carnitine shuttle. A defect in carnitine palmitoyltransferase I (CPT I) or a carnitine deficiency prevents this transport, leading to an inability to utilize long-chain fats during fasting, resulting in hypoketotic hypoglycemia and muscle weakness.

Fatty acid synthesis (lipogenesis) is essentially the reverse pathway, occurring in the cytoplasm and using acetyl-CoA carboxylase and fatty acid synthase. Cholesterol synthesis proceeds via the mevalonate pathway, with HMG-CoA reductase as the rate-limiting step and target of statin drugs. Lipid transport is mediated by lipoproteins: chylomicrons carry dietary lipids, VLDL carries endogenous triglycerides, LDL delivers cholesterol to tissues, and HDL participates in reverse cholesterol transport. Deficiencies in lipoprotein lipase or apolipoproteins lead to dramatic lipid disorders, such as familial hyperchylomicronemia, presenting with eruptive xanthomas and pancreatitis.

Nucleotide Synthesis: Purines, Pyrimidines, and Salvage

Nucleotide synthesis is divided into de novo pathways and salvage pathways. Purine synthesis builds the ring on a ribose-phosphate backbone, with the committed step catalyzed by glutamine phosphoribosyl pyrophosphate (PRPP) amidotransferase. The end product, IMP, is converted to AMP and GMP. A key regulatory enzyme in this pathway is ribonucleotide reductase, which converts NDPs to dNDPs for DNA synthesis. The salvage pathway for purines uses hypoxanthine-guanine phosphoribosyltransferase (HGPRT). A deficiency in HGPRT causes Lesch-Nyhan syndrome, characterized by hyperuricemia, self-mutilation, and neurological dysfunction.

Pyrimidine synthesis first constructs the ring (orotate) before attaching it to ribose-phosphate. A critical enzyme is carbamoyl phosphate synthetase II (CPS II), which is distinct from the urea cycle’s CPS I. Orotic aciduria can result from a deficiency in UMP synthase (in the de novo pathway) or, more rarely, from a defect in the urea cycle enzyme OTC, which causes mitochondrial orotic acid buildup due to substrate channeling.

Vitamins, Cofactors, and Enzyme Kinetics

Vitamins often act as cofactors or precursors for cofactors, which are essential for enzyme function. For example, niacin (B3) is a precursor for NAD+/NADH, and riboflavin (B2) is a precursor for FAD/FADH2. These cofactors are central to redox reactions in pathways like glycolysis, TCA cycle, and beta-oxidation. Thiamine (B1) deficiency impairs the PDH complex and alpha-ketoglutarate dehydrogenase, leading to beriberi (neurologic/cardiovascular symptoms) and Wernicke-Korsakoff syndrome. Cobalamin (B12) and folate are crucial for one-carbon metabolism and DNA synthesis; their deficiencies cause megaloblastic anemia and, in B12's case, neurological deterioration due to impaired methylmalonyl-CoA mutase function.

Understanding enzyme kinetics provides a framework for pharmacology and genetics. The Michaelis-Menten equation describes the relationship between substrate concentration and reaction velocity: $$v=\frac{V_{max}[S]}{K_m+[S]}$$. Here, $K_m$ is the substrate concentration at half-maximal velocity and reflects enzyme affinity. Competitive inhibitors increase the apparent $K_m$ without affecting $V_{max}$, while noncompetitive inhibitors decrease $V_{max}$ without affecting $K_m$. This is directly applicable: statins are competitive inhibitors of HMG-CoA reductase, and many antimetabolite chemotherapies act as competitive inhibitors in nucleotide synthesis pathways.

Inborn Errors of Metabolism: Clinical Synthesis

Inborn errors of metabolism are the ultimate clinical application of biochemical knowledge. They typically present in infancy or early childhood with catastrophic, often episodic, symptoms triggered by fasting or protein load. The general presentation can be remembered by the "intoxication" model: accumulation of toxic precursors proximal to a metabolic block. Key patterns to recognize:

• Hypoglycemia + Fatty Liver: Think of disorders affecting gluconeogenesis (e.g., fructose-1,6-bisphosphatase deficiency) or fatty acid oxidation (e.g., MCAD deficiency).
• Metabolic Acidosis with Elevated Anion Gap: Often due to lactic acidosis (e.g., PDH deficiency, mitochondrial disorders) or ketoacidosis.
• Hyperammonemia: Primarily points to urea cycle defects. The specific pattern of elevated orotic acid can help differentiate OTC deficiency (high orotic acid) from CPS I deficiency (normal orotic acid).
• Odd-Smelling Urine: Maple syrup urine disease (branched-chain amino acid accumulation), isovaleric acidemia ("sweaty feet" odor).

Common Pitfalls

1. Confusing Urea Cycle Enzymes: A common trap is mixing up carbamoyl phosphate synthetase I (mitochondrial, urea cycle) with carbamoyl phosphate synthetase II (cytosolic, pyrimidine synthesis). Remember: CPS I uses ammonia as its nitrogen source and is activated by N-acetylglutamate; CPS II uses glutamine.
2. Misidentifying Rate-Limiting Steps: It is critical to memorize the committed, rate-limiting step for each major pathway. For example, the rate-limiting step of de novo pyrimidine synthesis is CPS II, not the later step involving aspartate transcarbamoylase (ATCase), which is regulated in bacteria but not significantly in humans.
3. Overlooking Cofactor Connections: Students often memorize the vitamin deficiency disease but forget the specific biochemical pathways affected. Connect the vitamin to the enzyme. Pyridoxine (B6) deficiency causes microcytic anemia not just because it's a vitamin, but because it's a cofactor for aminolevulinic acid synthase in heme synthesis and for transaminases.
4. Ignoring Tissue-Specific Isozymes: Different tissues express different isoforms of enzymes with distinct regulatory properties. For example, glucokinase in the liver has a high $K_m$ and is not inhibited by glucose-6-phosphate, allowing the liver to respond to high blood glucose, while hexokinase in muscle has a low $K_m$ to ensure glucose uptake even during lower concentrations.

Summary

• Amino acid disorders like PKU and maple syrup urine disease result from blocks in catabolic pathways, leading to toxic precursor accumulation, often with neurological sequelae.
• Carbohydrate metabolism is tightly regulated; defects in gluconeogenesis (e.g., von Gierke's) or glycogenolysis present with profound hypoglycemia, while disorders like PDH deficiency cause lactic acidosis.
• Lipid metabolism defects in oxidation (e.g., MCAD deficiency) prevent ketone production during fasting, leading to hypoketotic hypoglycemia, while synthesis and transport disorders cause dyslipidemias.
• Nucleotide synthesis errors highlight the importance of salvage pathways; HGPRT deficiency (Lesch-Nyhan) causes behavioral and neurological issues alongside hyperuricemia.
• Vitamins act as essential enzyme cofactors; deficiencies disrupt the pathways they support (e.g., B1 in PDH, B12 in methionine synthesis and methylmalonyl-CoA metabolism).
• Clinical pattern recognition is paramount for inborn errors: look for episodic crises triggered by fasting, specific odors, organomegaly, and characteristic lab findings like hyperammonemia or an elevated anion gap acidosis.